Unresolved compliance issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's lead drug for spinal muscular atrophy (SMA). The CRL is related ...
It’s time to turn the tide on inequality. Read Oxfam’s latest report exposing just how extreme U.S. inequality has become, and join the movement to build a more equal future for us all. Billionaire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback